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Summary.-The effect of calusterone (7/3,17ax-dimethyltestosterone) on rat mam-
mary DMBA-induced adenocarcinoma was studied both in vivo and in organ culture.
In vivo all 8 tumours with a diameter of less than 30 mm regressed following
calusterone injection (10 mg/day for 2-3 weeks). In organ culture calusterone
(204kg/ml medium) inhibited the synthesis of DNA and RNA in all 7 cases examined.
Testosterone also inhibited the synthesis of DNA and RNA in organ culture in 12
out of 14 and 10 out of 14 tumours respectively. Oestradiol-17/3 on the other hand
had no effect on DNA and RNA synthesis in organ culture although 70%o of the
tumours examined were ovarian dependent, i.e. regressed following castration.
This could be explained by the direct effect of calusterone on rat adenocarcinoma
compared with the indirect effect of oestradiol-17/ which probably exerts its action
by activating the secretion of prolactin which acts on the tumour.
THE INDUCTION of mammary adeno-
carcinoma in the rat by feeding the
animal with 9,10,dimethyl-1,2,benzanthra-
cene (DMBA) is a model for the study
of hormone dependency in these tumours
(Huggins, Braziarelli and Sutton, 1959;
Huggins, Grand and Brilliantes, 1961;
Sterental et al., 1963; Heise and Gorlich,
1966; Klaiber et al., 1969; Teller et al.,
1969; Griswold and Green, 1970; Welsch
and Rivera, 1972).
Experimental mammary adenocarci-
noma in the rat can be classified as
ovarian dependent or ovarian indepen-
dent, depending on whether or not the
tumour regresses after ovariectomy. The
regression is probably caused by the
discontinuation of the excretion of the
ovarian steroid hormones. On the other
hand, steroid hormones like androgens
and also oestrogens are sometimes of
therapeutic value in the treatment of
breast cancer (Huggins et al., 1959;
Teller et al., 1969; Griswold and Gireen,
1970). Therefore, a tumour can be classi-
fied as sensitive to a certain steroid when
its growth is inhibited or stimulated by
this steroid. The anti-tumour efficacy of
a steroid may be related to its concentra-
tion in the blood, to its uptake and
metabolism by the tumour, and to its
effect on other target organs which in
turn secrete hormones that act on the
tumour.
Calusterone is highly effective in the
treatment ofhuman breast cancer (Gordan
et al., 1973). It therefore seems strange
that no anti-tumour efficacy had been
found in a previously reported animal
tumour system (Booth, 1968).
The present paper reports on the
direct effect, in organ culture, of calus-
terone on rat mammary adenocarcinoma
and the effect obtained by in vivo ad-
ministration ofthis hormone. The effects
of testosterone and oestradiol-17, in
organ culture and in vivo were also
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MATERIALS AND METHODS
Animals.-All animals were female inbred
rats, 7 weeks old, from the Lewis strain
(Lew/FMAI) grown in the HebrewUniversity-
Hadassah Medical School, Jerusalem, Israel.
The animals were maintained on rat pellets
and water ad libitum.
Carcinogen.-DMBA (9,10,dimethyl-1,2,-
benzanthracene) obtained from Sigma (St
Louis, Mo., U.S.A.) was dissolved in olive
oil (30 mg/ml) and shaken overnight. One
hundred and eighty rats were kept fasting
for 4 h and then fed with 30 mg of DMBA
through an intragastric tube (Huggins et
al., 1961). The animals were examined once
a week for the appearance of palpable
tumours. Three to 10 months after DMBA
feeding, 102 breast tumours appeared in 43
of 103 rats (2.4 tumours per animal). Tu-
mour-bearing rats were assigned to individual
groups (for ovariectomy, hormone administra-
tion or organ culture) on a random basis
as they became available.
Hormone dependency.-Animals with tu-
mours of 15-25 mm were ovariectomized
under ether anaesthesia. The effect of
bilateral overiectomy on regression or pro-
gression of a tumour was estimated by
caliper measurement of 2 diameters twice a
week during 4-6 weeks. It was considered
that a tumour regressed if its mean diameter
had decreased by 50% or more after 4 weeks.
A tumour which decreased in size after
castration was regarded as ovarian depen-
dent. When a tumour regressed, the animal
was injected with oestradiol-17fl (Ikapharm,
Ramat-Gan, Israel) subcutaneously, 5 ,ug
daily for 3-4 weeks according to the pro-
cedure of McGuire and Julian (1971). Ani-
mals carrying ovarian independent tumours
were not injected with oestradiol-17P.
The effect of calusterone (7f,177x-di-
methyltestosterone, obtained from Upjohn
Company, Kalamazoo, Mich, U.S.A.) was
tested in another group of animals with
DMBA-induced adenocarcinoma. Intact ani-
mals weighing about 250 g with a tumour
of 15-25 mm were injected s.c. daily for 2-3
weeks with 10 mg of calusterone dissolved
in 0-2 ml of No. 100 sterile vehicle (Upjohn
Company). Controls with the same tumour
size received only the sterile vehicle.
Organculture.-Organ culture of DMBA-
inducedadenocarcinoma wascarried outunder
aseptic conditions as described by Finkelstein
et al. (1975). The experiment was carried out
in triplicate and 2 dishes were used for
each sample. Therefore, 6 Petri dishes
were used for each hormone examined,
plus 6 Petri dishes for the " control " without
added hormone. Oestradiol-17/3 was added
in the concentration of 1 jug (in 0.01 ml
ethanol)/ml medium and testosterone (Ika-
pharm, Ramat-Gan, Israel) and calusterone
in the concentration of 20 ,ag (in 0-01 ml
ethanol)/ml medium. To the " control"
0-01 ml ethanol/ml medium was added.
After an initial 48 h culturing, the
explants from each dish were transferred
to a second dish containing 1-5 ml medium
of the same composition but with added
2 ,uCi/ml of methyl-3H-thymidine (sp. act.
> 10 Ci/mmol) and 0-3 /Ci/ml of 14C-uridine
(sp. act. 50 > mCi/mmol) both purchased
from the Nuclear Research Centre, Negev,
Israel. The samples were cultured for an
additional 48 h.
Incorporation of 3H-thymidine into DNA
and of '4C-uridine into RNA.-At the end
of the culturing period, the contents of every
2 dishes (from the same series), were pooled
and processed as one sample in the cold.
The tissue was washed 3 times with a buffer
solution consisting of 0X15 mol/l KC1, 0 003
mol/l NaHCO3 and 0X006 mol/l EDTA (pH
6-7) and homogenized with 2 ml of the
buffer in an all-glass homogenizer. Two ml
of 1 N perchloric acid (PCA) were added
to the homogenate. After 30 min at 4°C,
the homogenate was centrifuged for 10 min
at 3000 rev/min and the resultant precipitate
was washed twice with 0-5 N PCA and
recentrifuged atthe same speed. Thewashed
precipitate was suspended in 1 N NaOH,
shaken in a boiling water bath for
10 min and centrifuged at 3000 rev/min, for
10 min.
An aliquot of the supernatant was taken
for counting the radioactivity as reported
before (Finkelstein et at., 1975) and in
another aliquot the protein content was
estimated by the method of Lowry et al.
(1951). The synthesis of DNA and RNA
was calculated by the incorporation of
3H-thymidine and 14C-uridine into DNA
and RNA respectively per mg of protein.
The effect of the steroids on the synthesis
was calculated as percent of the mean
" control ". The range between 90 and
110% was considered as " no effect ".
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each tumour 3-4 randomly selected explants
were examined histologically before organ
culture in order to confirm the diagnosis
of adenocarcinoma. Randomly selected ex-
plants were also examined after organ
culture to further assess the viability of the
tissue in culture. The explants were fixed
in a 4% solution ofneutral buffered formalin.
After paraffin embedding, sections of 6 tim
were cut and stained with haematoxylin
and eosin and examined microscopically.
When the nuclear morphology was preserved
without pycnosis and when the nuclei
stained normally with haematoxylin, the
tissue was regarded as viable. Regressive
changes were determined by varying degrees
of pycnosis of the nuclei, karyorrhexis and
faint or no staining of the nuclei with
haematoxylin.
Statistical comparisons were performed
by the Wilcoxon matched pairs signed-rank
test (Siegel, 1956).
RESULTS
In vivo experiments
Ten animals, 7 with one tumour each,
2 with 2 tumours each and one animal
with 3 tumours were ovariectomized
(Table I). Of the 14 tumours examined,
10 regressed following ovariectomy and
TABLE I.-The Effect in vivo of Castration
and of Oestradiol-17/? Administration
on Rat DMBA Induced Adenocar-
cinomal
Animal and
tumour no.
I
II
III
IV
V
VI
VII
VIII a
VIII b
IX a
IX b
X a
X b
X c
Effect of
castration
R
R
R
R
R
R
p
R
R
R
p
p
p
R
Effect of
oestradiol-17,B*
p
p
p
R
R
p
NE
R, regression; P, progression; NE, no effect;
*, not injected.
* s.c. 5 jug/day for 3-4 weeks.
4 did not. In 3 cases (No. VIII, IX, X),
tumours in the same animal responded
differently to the ovariectomy. Six of
the animals whose tumours regressed
after ovariectomy were injected with
oestradiol-17/?. This caused 4 tumours
to grow, 2 continued to regress and in
one tumour no clear effect was obtained.
Nine intact animals with 11 adeno-
carcinomata (2 animals having 2 tumours
each) were injected with calusterone.
Of the 11 tumours examined, 8 regressed
following calusterone administration. The
3 tumours which did not regress were
unusually big (40, 46 and 47 mm mean
diameter) when the injections were start-
ed. Figure 1 shows the tumour diameter
curves (mean ± s.e.) of animals treated
with calusterone compared with 6 con-
trols.
Organ culture experiments
The effects of calusterone, testosterone
and oestradiol-17,B on explants of rat
adenocarcinoma in organ culture are
shown in Table II. Calusterone inhibited
the synthesis of DNA in all 7 cases
examined (P < 0.02) and the synthesis
of RNA was also inhibited in 6 of 7
cases (P < 0.05). Testosterone inhibited
the synthesis of DNA in 12 of 14 cases
and the RNA synthesis was inhibited in
10 cases (P < 0-01 in both tests). Oes-
tradiol-17,/ inhibited the syinthesis of
DNA in 6 of 10 cases, had no effect
in 3 and enhanced the synthesis of DNA
in one case. RNA synthesis was in-
hibited by oestradiol-17,/ in 5 cases and
stimulated in 2. (N.S. in both.)
All tissue samples grown in organ
culture in a steroid-free medium and
most samples grown with testosterone
and oestradiol-17,8 had a vital appearance.
Conversely, all samples in which calus-
terone was added to the medium under-
went complete or partial regressive
changes.
DISCUSSION
The effect of calusterone on rat
adenocarcinoma in organ culture and in
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TABLE II.-Effects of Calusterone, Testosterone and Oestradiol-17/3 on the Synthesis
of DNA and RNA in Organ Culture of Rat Adenocarcinomal
3H-Thymidine incorporation into DNA 14C-Uridine incorporation into RNA
Cont. ± s.e.
ct/min/ jsg prot.
84±13-0
39± 3-1
116± 17- 5
140± 9.4
314± 8- 6
128± 9-2
78+ 0
69± 7-8
79±12-0
143±18-0
55± 5-8
79± 5-3
22± 3-4
125± 15-7
Mean
S.D.
Statistical significance
Calust. Test. E2
Cont. ± s.e.
% incorporation of cont. ct/min/,ig prot.
71 95 10± 1- 6
40 75 5± 0-6
12* 36 34± 2- 7
69* 85 8± 1F1
62 120 26± 4-2
- 30 87 39± 3- 5
40 83 6± 0
lit 93 101 18± 2-0
67* 94 24+ 2- 3
46t 80 58* 8-4- 1-3
60t 87 29± 3-6
50* 57 27± 1-9
10* 81 105 9± 0,5
30* 64 77±10-6
39- 1 62- 8
22-7 24-7
P<0-02 P<0 01
82-0
24*3
N.S.
Calust. Test. E2
% incorporation of cont.
- 104 86
70 80
45 90
110 105
- 76 126
80 140
80 81
45 104 95
37 75
105 93 68
64 79
71 73
31 87 66
44 89
56- 7 83- 2
25-6 16-7
Pr<0-05 P<0.01
96-1
22-3
N.S.
Cont., control; Calust., calusterone; Test.,
Not significant.
* Partial regressive changes.
t Complete autolysis.
Tumour
db2er0
% 120
testosterone; E2, oestradiol-17fl. Prot., protein. N.S.
Calust. big tu
*Xii.. I Cahw
2 4 6 8 10 12 14 16
Days of treatment
FIG. 1. Percent change (mean ± s.e.) in tumour diameter following calusterone administration.
Controls injected with 0 2 ml sterile vehicle daily (6 tumours). Initial tumour diameter
15-25 mm (= 100%).----- Calusterone injected 10 mg/0. 2 ml sterile vehicle daily (8 tumours).
Initial tumour diameter 15-25 mm (= 100%). - Calusterone injected 10 mg/0 2 ml
sterile vehicle daily (3 tumours). Initial tumour diameter 40-47 mm (= 100%).
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Vio were compared. Using the technique
of organ cuilture makes it possible to
study the direct effect of a, hormone on
the tissue. Although the orgain cutlture
conditions caninot be regarded as physio-
logical, they resemble the physiological
conditions much more than an,y other in
vitro technique. The testosterone de-
rivative, ca,lusterone, ha,d an anti-tumour
effect in all the 7 tumours studied in
organ culture. Not only did it strongly
inhibit the incorporation of 3H-thymidine
into DNA acnd to a lesser extend also of
1'4C-uridine into RNA (P < 0 02 and
< 0-05 respectively, because oinly 7
samples were examined) buit histologically
regressive changes appeared after organ
culture whereas the " controls " and most
of the samples with added oestradiol-17/1
or testosteroine retained their vital ap-
pearance. Administration of calusterone
in vivo caused regression of all 8 tumours
with ain initial meain diameter of 30 mm
or less. In 3 tumours with a mean
diameter of 40, 46 and 47 mm calesterone
ha,d no effect in vivo. This is in agree-
ment with the report of Griswold and
G:reen (1970) who found tumour regression
after a,ndrogen administration (2a-methyl-
(lihydrotestosterolle propionate) only in
t,hose with a weight of 0-3-0i5 g whereas
tumours with a weight of 5-1-0 g did ilot
regress following aandrogen administra-
tion.
The alnti-tumour effect of calusterone
botil in orgaln culture and in vivo is very
interesting in view of the results obtained
in breast cancer patients and in ailimal
experiments in vivo. Cxordan et al. (1973)
found that 200 mg/day orally of caluste-
rone produced objective regressions in
51% of patients with advanced breast
cancer compared with only 21b5% after
testosterone propionate aind 160% after
stilboestrol. On the other hand, sub-
cutaneous administration of calusterone
5 mg/kg/day for 10 days to 6 Sprague-
Dawley rats with R1-35 mammary adeno-
carciiloma had 11o ailti-tumour effect
(Booth, 1968). Since in this publication
it was reported that calusterone is not
toxic to rats ill amotlIlts less thaln (68
mg/kg,/day, wre halve clioseni to inject the
animals with 10 mg of calusterolle dlaily
(40 mg/kg/day) as reported by Segalof
(1966) for testosterolle propionate. The
difference ill the in vivo restults with rat
adenocarcinonla couild be dtie to a, different
tumour tised in a differeilt stralin of rats.
In view of the report of Kim (1965) who
injected 0-1, I-() all(d 10-0 mg of testo-
sterone propionate into female rats with
adenocarcinioma aild founld that all 3
doses ha(d an inhibitory effect on tumotur
growth, aild lowest dose had the stroingest
effect, it seems that the different amount
of calusterone uised by us was ilot neces-
sarily the cause of the different results.
Our experimental nmodel with D)MBA-
induced adenocarcinoma ill Lewis female
rats apparently correlates better with
the in vrio results obtaiined in humaln
breast caincer patiellts as described by
Gordan et aIl. (1973).
In contrast to caltusterone which had
an anti-tumour effica,cy botil in orgall
cultture and in vivo, oestradiol-17/I had
practically no effect o11 the synthesis
of DNA anld RNA in organ cuilture, as was
also reported by Welsch an(d Rivera
(1972) for oestradiol-17/I at coilcelltratiolls
of 0-0001-b0 pig/ml. However, in our
experiment as well as in those of' others
(Htiggins et al., 1959; Kim ali(l Furth,
1960; Teller et al., 1969) 700% of the
tumours were ovariala dependent. This
could be explaiined by the asslimption
that calusterone acts directly on the
mammary adenocarcinomla, as judged by
the same effect obtained in vivo and in
organ culture. Oestradiol-17fl, on the
other hand, may exert its effect illdirectly
by activating other hormones such as
prolactin which acts on the tumour.
A variety of experiments hlave indicated
that oestrogens are mammary oncogenic
primarily as a result of their ability to
influence prolactin secretioni (Sterental et
al., 1963; Kim, 1965; Meites and Nicoll,
1966; Klaiber et al., 1 969; Welscli anld
Rivera, 1972). In the in vivo experiment,
where the animals were castrated1, regres-
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sion occurred because of the absence of
ovarian hormones to stimulate the secre-
tion of prolactin. Following regression
of tumours, the animals were injected
with 5,g daily of oestradiol-17,/. This
is a relatively small dose chosen to
reverse the effect of ovariectomy, as
described by Kim (1965) and McGuire and
Julian (1971). Larger doses ofoestradiol-
17,/, e.g. 30 ,tg (Kim, 1965) or 1200-1500
,ug daily (Teller et al., 1969) could have
been inhibitory.
The correlation between the effect
on adenocarcinoma in vivo and in organ
culture of other steroid hormones is
being investigated.
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